Absci (ABSI) stock forecast for 2024
Last update: 05-14-2022, 6:54
Sector: HealthcareThe share price of Absci Corporation (ABSI) now
What analysts predict:: $22.75
52-week high/low: $31.53 / $3.315
50/200 Day Moving Average: $7.2 / $11.19
This figure corresponds to the average price over the previous 50/200 days. For Absci stocks, the 50-day moving average is the resistance level today.
For Absci stocks, the 200-day moving average is the resistance level today.
Are you interested in Absci stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Absci stock price in 2024. How much will one Absci share be worth in 2024?
Is it worth taking profit / loss on Absci stock now or waiting? What are analysts' forecasts for Absci stock?
We forecast Absci stock performance using neural networks based on historical data on Absci stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
The Absci stock prediction results are shown below and presented as a graph, table and text information.
Absci stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Absci analysts is $22.75.
Today 200 Day Moving Average is the resistance level (11.19 $).
50 Day Moving Average is the resistance level (7.2 $).
Historical and forecast chart of Absci stock
The chart below shows the historical price of Absci stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Absci stock price can be found in the table below.
Absci (ABSI) Forecast for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 9.03 | 8.65 | 9.79 | 11.62 % |
| Feb | 7.19 | 6.74 | 8.32 | 19.05 % |
| Mar | 6.52 | 6.20 | 7.15 | 13.41 % |
| Apr | 7.11 | 6.58 | 7.89 | 16.66 % |
| May | 8.19 | 7.29 | 8.62 | 15.36 % |
| Jun | 8.93 | 7.75 | 10.37 | 25.31 % |
| Jul | 8.20 | 7.77 | 8.77 | 11.39 % |
| Aug | 9.75 | 8.74 | 10.73 | 18.50 % |
| Sep | 9.68 | 9.24 | 10.82 | 14.66 % |
| Oct | 10.21 | 9.44 | 10.84 | 12.87 % |
| Nov | 10.86 | 10.22 | 12.52 | 18.39 % |
| Dec | 8.76 | 7.36 | 9.72 | 24.23 % |
Absci information and performance
Absci Corporation, an artificial intelligence-powered synthetic biology company, offers candidate biologics and production cell lines using an integrated drug discovery platform for partners in the United States. Its integrated drug discovery platform enables biologics to be created by integrating drug discovery and cell line development into a single process. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Absci Address
18105 SE MILL PLAIN BLVD, VANCOUVER, WA, US
Market Capitalization: 355 604 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: - $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
DPS: N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: -2.078
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.468
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 20.29
Enterprise Value (EV) /Revenue
EV To EBITDA: -
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 92847000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Absci price target for 2021 by month
Target values for the price of one Absci share for Jan 2024.
Pessimistic target level: 8.65
Optimistic target level: 9.79
Target values for the price of one Absci share for Feb 2024.
Pessimistic target level: 6.74
Optimistic target level: 8.32
Target values for the price of one Absci share for Mar 2024.
Pessimistic target level: 6.20
Optimistic target level: 7.15
Target values for the price of one Absci share for Apr 2024.
Pessimistic target level: 6.58
Optimistic target level: 7.89
Target values for the price of one Absci share for May 2024.
Pessimistic target level: 7.29
Optimistic target level: 8.62
Target values for the price of one Absci share for Jun 2024.
Pessimistic target level: 7.75
Optimistic target level: 10.37
Target values for the price of one Absci share for Jul 2024.
Pessimistic target level: 7.77
Optimistic target level: 8.77
Target values for the price of one Absci share for Aug 2024.
Pessimistic target level: 8.74
Optimistic target level: 10.73
Target values for the price of one Absci share for Sep 2024.
Pessimistic target level: 9.24
Optimistic target level: 10.82
Target values for the price of one Absci share for Oct 2024.
Pessimistic target level: 9.44
Optimistic target level: 10.84
Target values for the price of one Absci share for Nov 2024.
Pessimistic target level: 10.22
Optimistic target level: 12.52
Target values for the price of one Absci share for Dec 2024.
Pessimistic target level: 7.36
Optimistic target level: 9.72